Universe Pharmaceuticals
UPCUniverse Pharmaceuticals Inc. (NASDAQ: UPC) is a China-based pharmaceutical company specializing in the development, manufacturing, and sale of traditional Chinese medicine (TCM) derivatives and medical products. The company’s primary business focus is on processing TCM ingredients into finished products, including granules, capsules, and tablets, for distribution within the domestic Chinese market. Its operations are vertically integrated, encompassing the cultivation of raw herbal materials through contracted farms, extraction and processing, and final pharmaceutical production. The company’s product portfolio is derived from a range of TCM formulas and is targeted at several therapeutic areas. Key products address conditions related to the cardiovascular and cerebrovascular systems, such as high cholesterol, as well as common ailments like coughs and colds. Other products focus on areas including internal medicine and gynecology. Universe Pharmaceuticals generates its revenue predominantly from the sale of these manufactured TCM products to distributors, hospitals, and pharmacies across China. As a publicly traded entity, Universe Pharmaceuticals operates manufacturing facilities in Jiangxi Province and reports its financial performance in accordance with regulatory requirements. The company’s strategy is centered on leveraging established TCM formulations through modern pharmaceutical production techniques to serve the domestic healthcare market.
UPC · Stock Price
Historical price data
About
Universe Pharmaceuticals Inc. (NASDAQ: UPC) is a China-based pharmaceutical company specializing in the development, manufacturing, and sale of traditional Chinese medicine (TCM) derivatives and medical products. The company’s primary business focus is on processing TCM ingredients into finished products, including granules, capsules, and tablets, for distribution within the domestic Chinese market. Its operations are vertically integrated, encompassing the cultivation of raw herbal materials through contracted farms, extraction and processing, and final pharmaceutical production. The company’s product portfolio is derived from a range of TCM formulas and is targeted at several therapeutic areas. Key products address conditions related to the cardiovascular and cerebrovascular systems, such as high cholesterol, as well as common ailments like coughs and colds. Other products focus on areas including internal medicine and gynecology. Universe Pharmaceuticals generates its revenue predominantly from the sale of these manufactured TCM products to distributors, hospitals, and pharmacies across China. As a publicly traded entity, Universe Pharmaceuticals operates manufacturing facilities in Jiangxi Province and reports its financial performance in accordance with regulatory requirements. The company’s strategy is centered on leveraging established TCM formulations through modern pharmaceutical production techniques to serve the domestic healthcare market.